Status:
RECRUITING
Prevalence of Tapia's Syndrome in Weaning Unit
Lead Sponsor:
Hopital Forcilles
Conditions:
Tapia's Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Tapia syndrome is a rare and poorly understood pathology. It is defined by a concomitant attack of the recurrent (branch of X) and hypoglossal (XII) nerves of peripheral or central origin. It is chara...
Detailed Description
The main aim of this study was to determine the prevalence of Tapia syndrome in patients admitted to weaning unit after prolonged (\>48h) orotracheal intubation in the ICU. The secondary objectives a...
Eligibility Criteria
Inclusion
- Hospitalized in weaning unit
- Duration of orotracheal intubation in the ICU greater than 48 hours;
- Glasgow score greater than or equal to 13 ;
- Patient at least 18 years of age at the time of inclusion;
- Affiliation with a social security system or beneficiary of such a system ;
- Oral, free, informed and express consent of the patient.
Exclusion
- Known history of ENT or neurological pathologies (stroke, head trauma, neurodegenerative disease, brain tumor, ENT cancer);
- Known tumors in the vicinity of the X-nerve pathway;
- Ortner's syndrome (left recurrent nerve compression through the left atrium in mitral stenosis);
- Left lung cancer with subaortic lesion;
- History of cervical adenopathy compressing the X nerve;
- Presence of a cervical or cerebral abscess;
- 24-hour ventilated patient;
- Refusal of the patient or designated trusted person to participate in the study;
- Person subject to a safeguard of justice measure ;
Key Trial Info
Start Date :
April 7 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 7 2027
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT06033144
Start Date
April 7 2023
End Date
April 7 2027
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Forcilles
Férolles-Attilly, Seine-et-Marne, France, 77150